Vanda Pharmaceuticals (VNDA) Assets (QoQ) (2011 - 2026)

Vanda Pharmaceuticals (VNDA) Assets (QoQ) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Vanda Pharmaceuticals 318.71 Mn 116.40 Mn 48.56 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -11.34%
Dec 31, 2025 -18.66%
Sep 30, 2025 -3.78%
Jun 30, 2025 -1.14%
Mar 31, 2025 -3.70%
Dec 31, 2024 1.72%
Sep 30, 2024 -0.96%
Jun 30, 2024 -0.20%
Mar 31, 2024 0.65%
Dec 31, 2023 1.07%
Sep 30, 2023 -0.01%
Jun 30, 2023 -0.44%
Mar 31, 2023 1.62%
Dec 31, 2022 2.00%
Sep 30, 2022 2.08%
Jun 30, 2022 0.92%
Mar 31, 2022 1.64%
Dec 31, 2021 2.42%
Sep 30, 2021 2.14%
Jun 30, 2021 4.50%